Emily Katz

Emily Katz

Director/BCW: Senior Vice President

202.530.4502

Emily Katz is a Senior Vice President with Burson Cohn & Wolfe (BCW) and serving with Prime Policy Group as a Director. With 15 years in Washington working on Capitol Hill and the private sector, Emily is an expert in health policy. She has developed and executed legislative and regulatory strategies on issues including drug pricing, public health, women’s health, diabetes, end of life care, health insurance and reform, and public programs including Medicare, Medicaid, and Tricare.

Prime Points

Prime Points

Differentiating Skills

Differentiating Skills

  • Deep expertise in all matters of health policy and strategies for driving legislative and regulatory change as well as oversight and investigations
  • Developing third-party alliances and coalitions
  • Corporate advocacy and direct interaction with C-suite executives
  • Advanced preparation for witnesses to testify before congressional committees
Past Experience

Past Experience

  • Senate Finance Committee Ranking Member Ron Wyden (D-OR)
  • Energy and Commerce Oversight and Investigations Subcommittee Chair Diana DeGette (D-CO)
  • Former Senate Environment and Public Works Chairman Barbara Boxer (D-CA)
  • Express Scripts
  • CIGNA
  • National Institutes of Health
  • Rockefeller University
Education

Education

  • BA (Biomedical Ethics) – Brown University;
  • Master of Public Health (Health Policy) – Columbia University Mailman School of Public Health
Did You Know?

Did You Know?

  • Even though Emily grew up in NYC, she spent a lot of her life white water kayaking and rafting and was a competitive marksman
  • Emily’s dogs are named Reggie Jackson and Bernie Williams
  • Emily’s daughter was born on Derek Jeter’s birthday
Read Full Bio

Emily Katz is a Senior Vice President with Burson Cohn & Wolfe (BCW) and serving with Prime Policy Group as a Director. With 15 years in Washington working on Capitol Hill and the private sector, Emily is an expert in health policy. She has developed and executed legislative and regulatory strategies on issues including drug pricing, public health, women’s health, diabetes, end of life care, health insurance and reform, and public programs including Medicare, Medicaid, and Tricare.

Prior to joining BCW and Prime Policy Group, Emily served as Senior Director of Government Affairs at Express Scripts where she advocated on behalf of the pharmacy benefit management (PBM) industry. Her strategic advocacy and industry coalition building efforts aided in the withdrawal by the Administration of the proposed “Rebate Rule.” She worked directly with executives who testified in front of Congress and the Senate. Emily also led advocacy efforts to ultimately enact legislation that would require electronic prescribing of opioids in Medicare.

Emily previously spent nine years on Capitol Hill, serving as a Legislative Assistant to now Senate Finance Committee Ranking Member Ron Wyden (D-OR), Health Policy Director to Chair of the House Energy & Commerce’s Subcommittee on Oversight & Investigations Diana DeGette (D-CO), and senior staff to Senator Barbara Boxer (D-CA), Chairman of the Environment and Public Works Committee. Her legislative accomplishments include more than a dozen of Senator Wyden’s amendments accepted into the 2010 health reform bill, enactment of the HIV Organ Policy Equity (HOPE) Act, and enactment of legislation to combat drug shortages.

Emily holds a Master of Public Health degree from Columbia University’s Mailman School of Public Health with a focus in Health Policy, and earned a Bachelor’s Degree in Biomedical Ethics from Brown University. She is a published scientific author and sits on the NoVa Advocates Council for Planned Parenthood Advocates for DC, Maryland, and Northern Virginia.

Published Content